Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122804502 | 12280450 | 2 | F | 20160718 | 20160419 | 20160720 | EXP | US-ASTRAZENECA-2016SE39548 | ASTRAZENECA | 0.00 | F | Y | 74.80000 | KG | 20160720 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122804502 | 12280450 | 1 | PS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5 MCG, 2 PUFFS TWICE DAILY | 21929 | BID | |||||||||
| 122804502 | 12280450 | 2 | SS | DALIRESP | ROFLUMILAST | 1 | Oral | 0 | 500 | UG | TABLET | QD | |||||||
| 122804502 | 12280450 | 3 | C | THEOPHYLLINE | THEOPHYLLINE ANHYDROUS | 1 | 0 | 400 | MG | QD | |||||||||
| 122804502 | 12280450 | 4 | C | BENZONATATE. | BENZONATATE | 1 | 0 | 100 | MG | BID | |||||||||
| 122804502 | 12280450 | 5 | C | PROAIR HFA | ALBUTEROL SULFATE | 1 | AS REQUIRED | 0 | |||||||||||
| 122804502 | 12280450 | 6 | C | IPRATROPRIUM BROMIDE ALBUTEROL SULFATE | 2 | EVERY FOUR HOURS | 0 | ||||||||||||
| 122804502 | 12280450 | 7 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | 0 | 325 | MG | TID | |||||||||
| 122804502 | 12280450 | 8 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | 0 | 5 | MG | QD | |||||||||
| 122804502 | 12280450 | 9 | C | PHENYTOIN SODIUM. | PHENYTOIN SODIUM | 1 | 0 | 100 | UG | TID | |||||||||
| 122804502 | 12280450 | 10 | C | AMLODIPINE BYSELATE | 2 | 0 | 5 | MG | QD | ||||||||||
| 122804502 | 12280450 | 11 | C | HYDROCHLORTHIAZIDE | HYDROCHLOROTHIAZIDE | 1 | 0 | 25 | MG | QD | |||||||||
| 122804502 | 12280450 | 12 | C | TRAMADOL. | TRAMADOL | 1 | EVERY SIX HOURS | 0 | |||||||||||
| 122804502 | 12280450 | 13 | C | PREVACID | LANSOPRAZOLE | 1 | 0 | ||||||||||||
| 122804502 | 12280450 | 14 | C | TUMS | CALCIUM CARBONATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122804502 | 12280450 | 1 | Chronic obstructive pulmonary disease |
| 122804502 | 12280450 | 2 | Chronic obstructive pulmonary disease |
| 122804502 | 12280450 | 3 | Chronic obstructive pulmonary disease |
| 122804502 | 12280450 | 4 | Cough |
| 122804502 | 12280450 | 6 | Dyspnoea |
| 122804502 | 12280450 | 7 | Anaemia |
| 122804502 | 12280450 | 8 | Antidepressant therapy |
| 122804502 | 12280450 | 9 | Seizure |
| 122804502 | 12280450 | 10 | Blood pressure abnormal |
| 122804502 | 12280450 | 11 | Blood pressure abnormal |
| 122804502 | 12280450 | 12 | Pain |
| 122804502 | 12280450 | 13 | Barrett's oesophagus |
| 122804502 | 12280450 | 14 | Barrett's oesophagus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122804502 | 12280450 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122804502 | 12280450 | Clostridium difficile colitis | |
| 122804502 | 12280450 | Cough | |
| 122804502 | 12280450 | Dyspnoea | |
| 122804502 | 12280450 | Hypotension | |
| 122804502 | 12280450 | Malaise | |
| 122804502 | 12280450 | Oxygen consumption decreased | |
| 122804502 | 12280450 | Pneumonia | |
| 122804502 | 12280450 | Septic shock |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |